
### [NCIT:C3780](http://purl.obolibrary.org/obo/NCIT_C3780)
**Label:** Large Cell Carcinoma

**Subclasses:** [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96157](http://purl.obolibrary.org/obo/NCIT_C96157) (Colorectal Large Cell Neuroendocrine Carcinoma), [NCIT:C8755](http://purl.obolibrary.org/obo/NCIT_C8755) (Stage I Large Cell Lung Carcinoma AJCC v7), [NCIT:C8756](http://purl.obolibrary.org/obo/NCIT_C8756) (Stage IV Large Cell Lung Carcinoma AJCC v7), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C8753](http://purl.obolibrary.org/obo/NCIT_C8753) (Recurrent Large Cell Lung Carcinoma), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C7266](http://purl.obolibrary.org/obo/NCIT_C7266) (Basaloid Large Cell Lung Carcinoma), [NCIT:C95582](http://purl.obolibrary.org/obo/NCIT_C95582) (Pancreatic Large Cell Neuroendocrine Carcinoma), [NCIT:C8231](http://purl.obolibrary.org/obo/NCIT_C8231) (Recurrent Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C136493](http://purl.obolibrary.org/obo/NCIT_C136493) (Large Cell Lung Carcinoma by AJCC v7 Stage), [NCIT:C126323](http://purl.obolibrary.org/obo/NCIT_C126323) (Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma), [NCIT:C95985](http://purl.obolibrary.org/obo/NCIT_C95985) (Ampulla of Vater Large Cell Neuroendocrine Carcinoma), [NCIT:C7906](http://purl.obolibrary.org/obo/NCIT_C7906) (Thyroid Gland Undifferentiated Carcinoma, Osteoclastic Variant), [NCIT:C35758](http://purl.obolibrary.org/obo/NCIT_C35758) (Stage 0 Large Cell Lung Carcinoma AJCC v6 and v7), [NCIT:C96958](http://purl.obolibrary.org/obo/NCIT_C96958) (Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma), [NCIT:C3878](http://purl.obolibrary.org/obo/NCIT_C3878) (Thyroid Gland Undifferentiated (Anaplastic) Carcinoma), [NCIT:C7998](http://purl.obolibrary.org/obo/NCIT_C7998) (Thymic Lymphoepithelioma-Like Carcinoma), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C9257](http://purl.obolibrary.org/obo/NCIT_C9257) (Stage III Large Cell Lung Carcinoma AJCC v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C6660](http://purl.obolibrary.org/obo/NCIT_C6660) (Stage II Large Cell Lung Carcinoma AJCC v7), [NCIT:C40214](http://purl.obolibrary.org/obo/NCIT_C40214) (Cervical Large Cell Neuroendocrine Carcinoma), [NCIT:C6461](http://purl.obolibrary.org/obo/NCIT_C6461) (Thymic Large Cell Neuroendocrine Carcinoma), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C126772](http://purl.obolibrary.org/obo/NCIT_C126772) (Endometrial Large Cell Neuroendocrine Carcinoma), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), [NCIT:C128075](http://purl.obolibrary.org/obo/NCIT_C128075) (Vaginal Large Cell Neuroendocrine Carcinoma), [NCIT:C6875](http://purl.obolibrary.org/obo/NCIT_C6875) (Large Cell Neuroendocrine Carcinoma), [NCIT:C6876](http://purl.obolibrary.org/obo/NCIT_C6876) (Large Cell Lung Carcinoma with Rhabdoid Phenotype), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C4450](http://purl.obolibrary.org/obo/NCIT_C4450) (Large Cell Lung Carcinoma), [NCIT:C4451](http://purl.obolibrary.org/obo/NCIT_C4451) (Large Cell Lung Carcinoma, Clear Cell Variant), [NCIT:C4452](http://purl.obolibrary.org/obo/NCIT_C4452) (Lung Giant Cell Carcinoma), [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610) (Oropharyngeal Undifferentiated Carcinoma), [NCIT:C95885](http://purl.obolibrary.org/obo/NCIT_C95885) (Gastric Large Cell Neuroendocrine Carcinoma), [NCIT:C128245](http://purl.obolibrary.org/obo/NCIT_C128245) (Vulvar Large Cell Neuroendocrine Carcinoma), [NCIT:C35736](http://purl.obolibrary.org/obo/NCIT_C35736) (Salivary Gland Lymphoepithelial Carcinoma), [NCIT:C35735](http://purl.obolibrary.org/obo/NCIT_C35735) (Salivary Gland Large Cell Carcinoma), [NCIT:C96065](http://purl.obolibrary.org/obo/NCIT_C96065) (Small Intestinal Large Cell Neuroendocrine Carcinoma), [NCIT:C4107](http://purl.obolibrary.org/obo/NCIT_C4107) (Nasopharyngeal Type Undifferentiated Carcinoma), [NCIT:C3779](http://purl.obolibrary.org/obo/NCIT_C3779) (Giant Cell Carcinoma), [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), [NCIT:C54342](http://purl.obolibrary.org/obo/NCIT_C54342) (Laryngeal Giant Cell Carcinoma), [NCIT:C8225](http://purl.obolibrary.org/obo/NCIT_C8225) (Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C8223](http://purl.obolibrary.org/obo/NCIT_C8223) (Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8023](http://purl.obolibrary.org/obo/NCIT_C8023) (Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma), [NCIT:C96426](http://purl.obolibrary.org/obo/NCIT_C96426) (Appendix Large Cell Neuroendocrine Carcinoma), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), 

**Class expressions from DL-Learner:**

- [NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation) 66.67%
- Thing 51.13%
- [NCIT:C42095](http://purl.obolibrary.org/obo/NCIT_C42095) (Tissue Differentiation) 46.24%
- [NCIT:C43573](http://purl.obolibrary.org/obo/NCIT_C43573) (Glandular Differentiation) 45.53%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 36.96%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 36.82%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 35.85%
- [NCIT:C36822](http://purl.obolibrary.org/obo/NCIT_C36822) (Malignant Epithelial Large Cell) 35.56%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 35.25%
- [NCIT:C37162](http://purl.obolibrary.org/obo/NCIT_C37162) (Neoplastic Large Cell) 23.47%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 22.29%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 22.12%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 21.12%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 21.10%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.90%


